ICAM1 and neoplasm: Taken together, these data suggest that depleting platelet or inhibiting ICAM‐1 suppresses tumor growth and metastasis after insufficient RFA, and ICAM‐1 activates platelets and leads to increased endothelial permeability after insufficient RFA (Figure 7).